nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—Conduction disorder—Hydrochlorothiazide—nephrolithiasis	0.0955	0.0955	CcSEcCtD
Reboxetine—Hair disorder—Hydrochlorothiazide—nephrolithiasis	0.0881	0.0881	CcSEcCtD
Reboxetine—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.038	0.038	CcSEcCtD
Reboxetine—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0357	0.0357	CcSEcCtD
Reboxetine—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0278	0.0278	CcSEcCtD
Reboxetine—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0243	0.0243	CcSEcCtD
Reboxetine—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0216	0.0216	CcSEcCtD
Reboxetine—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0211	0.0211	CcSEcCtD
Reboxetine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0204	0.0204	CcSEcCtD
Reboxetine—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0204	0.0204	CcSEcCtD
Reboxetine—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0164	CcSEcCtD
Reboxetine—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0157	CcSEcCtD
Reboxetine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0146	0.0146	CcSEcCtD
Reboxetine—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0144	CcSEcCtD
Reboxetine—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.014	0.014	CcSEcCtD
Reboxetine—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0136	CcSEcCtD
Reboxetine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Reboxetine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0133	CcSEcCtD
Reboxetine—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0131	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Reboxetine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Reboxetine—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0126	CcSEcCtD
Reboxetine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0117	CcSEcCtD
Reboxetine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Reboxetine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Reboxetine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0113	CcSEcCtD
Reboxetine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Reboxetine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Reboxetine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Reboxetine—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0106	CcSEcCtD
Reboxetine—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Reboxetine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Reboxetine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Reboxetine—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00997	0.00997	CcSEcCtD
Reboxetine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00968	0.00968	CcSEcCtD
Reboxetine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00937	0.00937	CcSEcCtD
Reboxetine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00858	0.00858	CcSEcCtD
Reboxetine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00856	0.00856	CcSEcCtD
Reboxetine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00849	0.00849	CcSEcCtD
Reboxetine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00819	0.00819	CcSEcCtD
Reboxetine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00811	0.00811	CcSEcCtD
Reboxetine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00808	0.00808	CcSEcCtD
Reboxetine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00804	0.00804	CcSEcCtD
Reboxetine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00789	0.00789	CcSEcCtD
Reboxetine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00786	0.00786	CcSEcCtD
Reboxetine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00784	0.00784	CcSEcCtD
Reboxetine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00783	0.00783	CcSEcCtD
Reboxetine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00773	0.00773	CcSEcCtD
Reboxetine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00769	0.00769	CcSEcCtD
Reboxetine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00745	0.00745	CcSEcCtD
Reboxetine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00742	0.00742	CcSEcCtD
Reboxetine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00736	0.00736	CcSEcCtD
Reboxetine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00728	0.00728	CcSEcCtD
Reboxetine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0072	0.0072	CcSEcCtD
Reboxetine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00702	CcSEcCtD
Reboxetine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00697	0.00697	CcSEcCtD
Reboxetine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0069	0.0069	CcSEcCtD
Reboxetine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0068	0.0068	CcSEcCtD
Reboxetine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00667	0.00667	CcSEcCtD
Reboxetine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00646	0.00646	CcSEcCtD
Reboxetine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00641	0.00641	CcSEcCtD
Reboxetine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00636	0.00636	CcSEcCtD
Reboxetine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00634	0.00634	CcSEcCtD
Reboxetine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00628	0.00628	CcSEcCtD
Reboxetine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0062	0.0062	CcSEcCtD
Reboxetine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0061	0.0061	CcSEcCtD
Reboxetine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00588	0.00588	CcSEcCtD
Reboxetine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00584	CcSEcCtD
Reboxetine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00567	0.00567	CcSEcCtD
Reboxetine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00564	0.00564	CcSEcCtD
Reboxetine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00564	0.00564	CcSEcCtD
Reboxetine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00526	0.00526	CcSEcCtD
Reboxetine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00512	0.00512	CcSEcCtD
Reboxetine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00488	0.00488	CcSEcCtD
Reboxetine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00472	0.00472	CcSEcCtD
Reboxetine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00454	0.00454	CcSEcCtD
Reboxetine—Rash—Hydrochlorothiazide—nephrolithiasis	0.0045	0.0045	CcSEcCtD
Reboxetine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0045	0.0045	CcSEcCtD
Reboxetine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00447	0.00447	CcSEcCtD
Reboxetine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00424	0.00424	CcSEcCtD
